Safety and efficacy of low dose simvastatin in cardiac transplant recipients treated with cyclosporine

Hyperlipidemia is common in heart transplant patients. Lipid-lowering therapy poses special problems, yet may be important because accelerated graft atherosclerosis is the major factor limiting long-term survival. Simvastatin 5 mg/day was started > 6 months after surgery in 26 consecutive cardiac...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Transplantation 1994-07, Vol.58 (1), p.42-45
Hauptverfasser:	VANHAECKE, J, VAN CLEEMPUT, J, VAN LIERDE, J, DAENEN, W, DE GEEST, H
Format:	Artikel
Sprache:	eng
Schlagworte:	Anticholesteremic Agents - administration & dosage Anticholesteremic Agents - adverse effects Biological and medical sciences Cholesterol - blood Cyclosporine - therapeutic use Female Follow-Up Studies Graft Survival - drug effects Heart Transplantation - adverse effects Humans Hypercholesterolemia - drug therapy Hypercholesterolemia - prevention & control Immunomodulators Lovastatin - administration & dosage Lovastatin - adverse effects Lovastatin - analogs & derivatives Male Medical sciences Middle Aged Pharmacology. Drug treatments Simvastatin Triglycerides - blood
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!